Klinische Studien


1.

Diagnostik der nekrotisierenden Pankreatitis. Vergleich von Kontrastmittel-CT und Ultraschall in einer klinischen Studie.
Block S, Maier W, Clausen C, Büchler M, Malfertheiner P, Beger HG.
Dtsch Med Wschr 21 (1985), 826-832


2.

Gabexat Mesilat in der Therapie der akuten Pankreatitis. Ergebnisse einer multizentrischen offenen klinischen Studie.
Büchler M, Malfertheiner P, Uhl W, Wolf HRD, Schwab G, Beger HG.
Med Klinik 83 (1988), 320-324


3.

Prävalanz und Wertigkeit der jodinduzierten Hyperthyreose nach Kontrastmitteluntersuchung: Ergebnis einer kontrollierten klinischen Studie.
Schwarz M, Büchler M, Rank J, Friedrich J, Beger HG.
Langenbeck’s Archives of Surgery, Suppl Chir Forum (1990), 301-304


4.

A randomized controlled trial of adjuvant immotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.
Büchler M, Friess H, Schultheiß KH, Gebhardt Ch, Muhrer KH, Winkelmann M, Wagner Th, Klapdor R, Kaul M, Müller G, Schulz G, Beger HG.
Cancer 68 (1991), 1507-1512


5.

Role of serum phospholipase A2 in surgical intensive care patients: a prospective multicenter study.
Poch B, Büchler M, Hoffmann G, Vogeser M, Beger HG and the PLA2 Multicenter Study Group.
Langenbeck’s Archives of Surgery, Suppl Chir Forum (1992), 441-448


6.

Laparoskopische Cholecystektomie versus mini-lap Cholecystektomie. Ergebnisse einer prospektiven, randomisierten Studie.
Kunz R, Orth K, Vogel, Steinacher JM, Meitinger A, Brückner UB, Beger HG.
Chirurg 63 (1992), 291-295


7.

Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany.
Friess H, Klempa H, Hermanek P, Sulkowski U, Uhl W, Beger HG, Büchler M Digestion 55/S1 (1994), 35-40


8.

Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis.
Büchler M, Friess H, Müller MM, Beger HG.
Am J Surg 169 (1995), 65-70


9.

Diagnosis of pancreatic cancer by 2(18F)-flouro-2-deoxy D-glucose positron emission tomography.
Friess H, Langhans, J, Ebert M, Beger HG, Stollfuß J, Reske SN, Büchler M.
Gut 36 (1995), 771-777


10.

Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study.
Schwarz A, Büchler M, Usinger K, Rieger H, Glasbrenner B, Friess H, Kunz R, Beger HG.
World J Surg 20 (1996), 60-67


11.

Regional chemotherapy directed by individual chemosensitivity testing in vitro: A prospective decision-aiding trial.
Link KH, Kornmann, M, Leder GH, Butzer U, Pillasch J, Staib L, Gansauge F, Beger HG.
Clinical Cancer Research 2 (1996), 1469-1474


12.

Antibiotika bei nekrotisierender Pankreatitis. Ergebnisse einer kontrollierten Studie.
Schwarz M, Isenmann R, Meyer H, Beger HG
DMW 122 (1997), 356-361


13.

A randomized, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.
Uhl W, Büchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W and the German Pancreatits Study Group.
Gut 45 (1999), 97-104


14.

Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease. A single-center experience.
Beger HG, Schlosser W, Friess HM, Büchler MW.
Ann Surg 230 (1999) 512-523


15.

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.
Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MGT, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA.
The Lancet 355 (2000) 1955-1960


16.

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Neoptolemos JP, Dunn JA, Stocken DD, Almond J, K Link, H Beger, C Bassi, M Falconi, P Pederzoli, C Dervenis, L Fernandez-Cruz, F Lacaine, A Pap,
D Spooner, DJ Kerr, H Friess, MW Büchler.
The Lancet 2001, 358, 1576-85


17.

Prophylactic ciprofoxacin/ metronidazole therapy in patients with severe acute pancreatitis – results of a double-blinded placebo-controlled multicenter trial.
R Isenmann, M Rünzi, M Kron, S Kahl, D Kraus, M Jung, L Maier, P Malfertheiner, H Goebell, HG Beger + ASAP Study Group
Gastroenterology 2004; 126: 997-2008



18.

A randomized trial of chemoradiatherapy and chemotherapy after resection of pancreatic cancer.
JP Neoptolemos, D Stocken, H Friess, C Bassi, J Dunn, HG Beger et al. (ESPAC)
New England of Medicine (2004); 350: 1200-1210


19.

Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + Levamisole with Folinic Acid or with Interferon-α.
KH Link, M Kornmann, L Staib, ED Kreuser, W Gaus, HF Weiser, E Kettner, J Albrecht, W Baumann, H Schramm, M Lausen, R Bittner, B Leibl, M Redenbacher, Rudolf Roscher, U Schenker, KU Zerbian, J Vogt, J Gabriel, WJ Stelter, W Schmidt, T Liersch, P Mattes, H Bewersdorf, B Karn, M Schatz, M Kron, HG Beger
Annals of Surgery
2005; 242: 178-187


20.

Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study
Rau BM, Kemppainen EA, Gumbs AA, Büchler MW, Wagscheider K, Bassi C, Pudakkainen PA, Beger HG
Annales of Surgery 2007, 245: 745-754


 
Kontakt Impressum/ Disclaimer